OR WAIT null SECS
Sponsored by Movilitas
Every year in the United States, millions of pharmaceutical products are returned in saleable condition. Yet,
manufacturers and wholesalers must meet DSCSA regulations in order to resell these items. Complying can be a challenge unless the right solution is in place.
According to the Healthcare Distribution Alliance (HDA):
The next DSCSA requirement is for saleable returns verification. It regulates how wholesalers can legitimately sell returned medicines.
By Nov. 27, 2020, wholesale distributors must verify the serialized product identifiers of any saleable returned pharmaceuticals with the help of manufacturers. The compliance process is complex.
There can be lags in verification because many wholesale distributors currently rely on point-to-point solutions or manual processes. This lost time results in process disruptions and delays that can cost money and sales. A better way is a cloud solution that provides real-time feedback of product authenticity to minimize operational impacts.
Learn more from the guide How to Comply with the DSCSA Saleable Returns Verification Requirement. It covers: